Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Other financing activities (2024 - 2025)

Zenas BioPharma has reported Other financing activities over the past 2 years, most recently at $9.3 million for Q4 2025.

  • Quarterly results put Other financing activities at $9.3 million for Q4 2025, up 108.83% from a year ago — trailing twelve months through Dec 2025 was $15.0 million (up 137.12% YoY), and the annual figure for FY2025 was $12.7 million, up 99.95%.
  • Other financing activities for Q4 2025 was $9.3 million at Zenas BioPharma, up from $4.5 million in the prior quarter.
  • Over the last five years, Other financing activities for ZBIO hit a ceiling of $9.3 million in Q4 2025 and a floor of $439000.0 in Q3 2024.